Title |
Author |
Type |
Date |
Words |
Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy. |
|
|
Jan 7, 2021 |
581 |
Amber Specialty Pharmacy Selected by PTC Therapeutics to Dispense Emflaza for Duchenne Muscular Dystrophy Patients. |
|
|
Oct 12, 2020 |
309 |
Italfarmaco Receives FDA Rare Pediatric Disease Designation for Givinostat in Duchenne Muscular Dystrophy, Announces Completed Enrollment in EPIDYS Phase 3 Trial. |
|
|
Oct 12, 2020 |
586 |
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy. |
|
|
Oct 2, 2020 |
345 |
FDA approves viltolarsen for Duchenne muscular dystrophy. |
Brooks, Megan |
|
Oct 1, 2020 |
375 |
Pharmaxis awarded A$1 million to progress Duchenne Muscular Dystrophy drug into the clinic. |
|
|
Sep 4, 2020 |
758 |
US FDA approves NS Pharma's Viltepso (viltolarsen) Duchenne muscular dystrophy injection. |
|
|
Aug 13, 2020 |
216 |
US FDA approves NS Pharma's Viltepso (viltolarsen) Duchenne muscular dystrophy injection. |
|
|
Aug 13, 2020 |
212 |
Duchenne Muskuler Distrofi ve Spinal Muskuler Atrofi Tanisi Alan Pediyatrik Hastalarda Uykunun Yapisinin ve Uyku ile Iliskili Hastaliklarin Incelenmesi/Evaluation of Sleep Structure and Sleep-related Disorders in Pediatric Patients Diagnosed with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy. |
Arkali, Nuran Burcu; Senel, Gulcin Benbir; Kilic, Huseyin; Incesu, Gunduz; Saltik, Sema; Yalcinkaya, |
Disease/Disorder overview |
Mar 1, 2020 |
2918 |
Orsini Pharmaceutical Services Selected to Provide Vyondys 53 Injection for Duchenne Muscular Dystrophy. |
|
|
Feb 11, 2020 |
207 |
Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy. |
|
|
Dec 23, 2019 |
867 |
Spironolactone Noninferior in Duchenne Muscular Dystrophy; Spironolactone noninferior to eplerenone for preserving cardiac contractility in boys with Duchenne. |
|
|
Oct 28, 2019 |
237 |
Catabasis Pharmaceuticals Presents Edasalonexent, a Potential Foundational Treatment for Duchenne Muscular Dystrophy. |
|
|
Oct 9, 2019 |
544 |
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market by Type & Geography (2019-2023). |
|
|
Sep 10, 2019 |
739 |
The relationship of bone mineral density and vitamin D levels with steroid use and ambulation in patients with Duchenne muscular dystrophy. |
Sertpoyraz, Filiz Meryem; Tiftikcioglu, Bedile Irem |
|
Sep 1, 2019 |
3629 |
Sarepta Plunges After FDA Spurns Its Second Duchenne Muscular Dystrophy Drug. |
|
|
Aug 20, 2019 |
408 |
Global Duchenne Muscular Dystrophy Drugs Market Report, 2019-2025 - Mutation Suppression Displays the Potential to Grow at Over 40.2%. |
|
Report |
Aug 7, 2019 |
714 |
Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy. |
|
|
Jul 2, 2019 |
954 |
Catabasis Pharmaceuticals Presents Preclinical Data Showing Potential for Bone Preservation with Edasalonexent in Duchenne Muscular Dystrophy. |
|
|
Jun 27, 2019 |
780 |
Global Duchenne Muscular Dystrophy (DMD) Market Spotlight 2017-2018 & 2019-2026. |
|
|
Jun 19, 2019 |
903 |
Universal Credit 'error' leaves parents of terminally ill girl with 'nothing'; Brendan and Kelly-Anne Shortall say they don't have enough money to take their daughter Hannah, who has Duchenne muscular dystrophy, on a day out. |
|
|
May 30, 2019 |
825 |
Biochemical Changes in Blood of Patients with Duchenne Muscular Dystrophy Treated with Granulocyte-Colony Stimulating Factor. |
Sienkiewicz, Dorota; Kulak, Wojciech; Paszko-Patej, Grazyna; Okurowska-Zawada, Bozena; Sienkiewicz, |
|
Mar 31, 2019 |
4247 |
Catabasis Pharmaceuticals Presents Data Supporting Edasalonexent as a Potential Foundational Treatment for Duchenne Muscular Dystrophy. |
|
|
Feb 20, 2019 |
671 |
Researchers Discover A Way To Treat Duchenne Muscular Dystrophy. |
|
|
Feb 11, 2019 |
471 |
Charity boxing night set to raise funds for young boy with a degenerative disease; Proceeds will help fund equipment for Jenson Edwards who was diagnosed with Duchenne muscular dystrophy at three and is likely to be wheelchair-bound by 11. |
|
|
Dec 2, 2018 |
268 |
Catabasis Pharmaceuticals Publishes Phase 1 Clinical Results of Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy. |
|
|
Nov 29, 2018 |
490 |
Catabasis Pharmaceuticals Starts Phase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular Dystrophy. |
|
|
Sep 26, 2018 |
627 |
Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. |
|
|
Sep 3, 2018 |
154 |
Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. |
|
|
Sep 3, 2018 |
150 |
CRISPR Halts Duchenne Muscular Dystrophy. |
|
|
Sep 2, 2018 |
592 |
Pfizer Terminates Domagrozumab Clinical Studies for the Treatment of Duchenne Muscular Dystrophy. |
|
Clinical report |
Aug 31, 2018 |
563 |
PTC Therapeutics Publishes Data Demonstrating Benefit of Deflazacort in Duchenne Muscular Dystrophy. |
|
Clinical report |
Jul 26, 2018 |
356 |
Grandfather walking 500 miles to help three-year-old grandson with life-limiting illness; Three-year-old Lincoln was dagnosed in December 2016 with Duchenne Muscular Dystrophy (DMD). |
|
|
Jun 22, 2018 |
470 |
Results of Catabasis Pharmaceuticals Trial of Edasalonexent in Duchenne Muscular Dystrophy to be Presented at American Academy of Neurology 70th Annual Meeting. |
|
|
Apr 20, 2018 |
246 |
Molecular Analysis-Based Genetic Characterization of a Cohort of Patients with Duchenne and Becker Muscular Dystrophy in Eastern China. |
Zhao, Hui-Hui; Sun, Xue-Ping; Shi, Ming-Chao; Yi, Yong-Xiang; Cheng, Hong; Wang, Xing-Xia; Xu, Qing- |
Report |
Apr 15, 2018 |
4188 |
US EAP for Idebenone for Duchenne Muscular Dystrophy Patients Launched by Clinigen and Santhera. |
|
|
Feb 22, 2018 |
259 |
Mum's heartbreaking poem for terminally ill son made into everlasting memory; Seven-year-old Toby suffers with Duchenne Muscular Dystrophy (DMD). |
|
|
Jan 21, 2018 |
669 |
Gestational Outcomes of Pregnant Women Who Have Had Invasive Prenatal Testing for the Prenatal Diagnosis of Duchenne Muscular Dystrophy. |
Beksac, Mehmet Sinan; Tanacan, Atakan; Hakli, Duygu Aydin; Orgul, Gokcen; Soyak, Burcu; Hayta, Burcu |
|
Jan 1, 2018 |
3293 |
Fat Embolism Syndrome in Duchenne Muscular Dystrophy Patients: Early Recognition and Aggressive Therapy. |
Murphy, Lee D.; Yabrodi, Mouhammad; Lutfi, Riad |
|
Jan 1, 2018 |
1935 |
Wave Life Sciences Commences Clinical Trial of WVE-210201 in Boys 5 to 18 Years Old with Duchenne Muscular Dystrophy. |
|
Clinical report |
Nov 7, 2017 |
394 |
Capricor Presents 12-Month Results from HOPE-1 Trial in Duchenne Muscular Dystrophy. |
|
|
Oct 25, 2017 |
392 |
Relevant aspects of golden retriever muscular dystrophy for the study of Duchenne muscular dystrophy in humans/Aspectos relevantes da distrofia muscular do golden retriever para o estudo da distrofia muscular de Duchenne em humanos. |
de Moraes, Julieta Rodini Engracia; Malvestio, Lygia Maria Mouri; Martins, Isabela Mancini; Mosko, P |
Ensayo |
Oct 1, 2017 |
7455 |
Capricor Therapeutics Names PI for Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy. |
|
|
Sep 27, 2017 |
359 |
FDA Indicates Willingness to Accept Capricor's Proposed Clinical Development Plan for Intravenous CAP-1002 for Duchenne Muscular Dystrophy. |
|
|
Jul 28, 2017 |
342 |
ASSOCIATION OF DEVELOPMENTAL DELAY, CONGENITAL ADRENAL HYPOPLASIA, DUCHENNE MUSCULAR DYSTROPHY AND GLYCEROL KINASE DEFICIENCY: A RARE Xp21 CONTIGUOUS GENE DELETION SYNDROME. |
Altundag, Engin; Kara, Cengiz; Sanri, Aslihan; Albayrak, Hatice Mutlu; Yalcin, Hatice Yelda; Ogur, G |
Case study |
Jun 1, 2017 |
328 |
Six-month results from clinical trial in duchenne muscular dystrophy. |
|
|
May 1, 2017 |
806 |
Six-month results from clinical trial in duchenne muscular dystrophy. |
|
|
May 1, 2017 |
805 |
Catabasis Pharmaceuticals Touts Favourable Functional Assessment Results in MoveDMD Trial for Edasalonexent in Duchenne Muscular Dystrophy. |
|
|
Apr 25, 2017 |
624 |
Nicotinamide riboside shows promise for Duchenne muscular dystrophy. |
|
Report |
Apr 1, 2017 |
234 |
Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy. |
Moat, Stuart J.; Korpimaki, Teemu; Furu, Petra; Hakala, Harri; Polari, Hanna; Merio, Liisa; Makinen, |
Report |
Apr 1, 2017 |
4492 |
Solid Biosciences Raises up to USD 50m; Will Use for Duchenne Muscular Dystrophy Portfolio. |
|
|
Mar 31, 2017 |
301 |
PTC Therapeutics to purchase Emflaza for the treatment of Duchenne Muscular Dystrophy in the US from Marathon. |
|
|
Mar 17, 2017 |
278 |
PTC Therapeutics to purchase Emflaza for the treatment of Duchenne Muscular Dystrophy in the US from Marathon. |
|
|
Mar 17, 2017 |
274 |
Catabasis Pharmaceuticals Posts Mixed Top-Line Results for Part B of Trial for Edasalonexent in Duchenne Muscular Dystrophy. |
|
|
Feb 1, 2017 |
288 |
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy. |
Gee, Peter; Xu, Huaigeng; Hotta, Akitsu |
Report |
Jan 1, 2017 |
8333 |
A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the mdx Dystrophic Mouse. |
Craig, Robert Wright; Allsopp, Giselle Larissa; Addinsall, Alex Bernard; McRae, Natasha Lee; Andriko |
Report |
Jan 1, 2017 |
7003 |
Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status. |
Miyagoe-Suzuki, Yuko; Nishiyama, Takashi; Nakamura, Miho; Narita, Asako; Takemura, Fusako; Masuda, S |
Report |
Jan 1, 2017 |
5342 |
Sarepta Therapeutics receives EMA validation of eteplirsen's MAA for Duchenne Muscular Dystrophy amenable to exon skipping 51. |
|
|
Dec 20, 2016 |
299 |
Sarepta Therapeutics receives EMA validation of eteplirsen's MAA for Duchenne Muscular Dystrophy amenable to exon skipping 51. |
|
|
Dec 20, 2016 |
303 |
Company finishes enrollment in Duchenne muscular dystrophy trial. |
|
|
Sep 12, 2016 |
378 |
My family's journey with Duchenne muscular dystrophy; as we wait to see what will happen, I take each day as it comes and continue to fight to make sure my boys will have access to this drug--it is our only hope at this stage. |
Vertin, Betty |
|
Aug 1, 2016 |
1469 |
Biomarin's regulatory submissions for Kyndrisa Duchenne muscular dystrophy drug withdrawn. |
|
|
Jun 2, 2016 |
187 |
Biomarin's regulatory submissions for Kyndrisa Duchenne muscular dystrophy drug withdrawn. |
|
|
Jun 2, 2016 |
183 |
PTC Therapeutics announces NICE's recommendation for Translarna (ataluren) for treating nonsense mutation Duchenne Muscular Dystrophy in England. |
|
|
Apr 18, 2016 |
302 |
PTC Therapeutics announces NICE's recommendation for Translarna (ataluren) for treating nonsense mutation Duchenne Muscular Dystrophy in England. |
|
|
Apr 18, 2016 |
298 |
DEVASTATING; Families' despair as watchdogs turn down PS200k-a-year Duchenne muscular dystrophy treatment that transformed their boys' lives. |
|
|
Apr 12, 2016 |
290 |
Just Published: "Duchenne Muscular Dystrophy - Pipeline Review, H1 2016". |
|
|
Apr 8, 2016 |
480 |
PTC Therapeutics introduces second annual STRIVE rant award programme for Duchenne muscular dystrophy. |
|
|
Feb 15, 2016 |
192 |
PTC Therapeutics introduces second annual STRIVE rant award programme for Duchenne muscular dystrophy. |
|
|
Feb 15, 2016 |
188 |
Stem cell gene therapy could be key to treating Duchenne muscular dystrophy. |
|
|
Feb 1, 2016 |
781 |
Now Available: Duchenne Muscular Dystrophy - Pipeline Review, H2 2015. |
|
|
Jan 20, 2016 |
480 |
Scientists stop Duchenne muscular dystrophy with gene editing. |
|
|
Jan 1, 2016 |
258 |
Duchenne muscular dystrophy is a genetic stem cell disease. |
|
|
Nov 23, 2015 |
477 |
World Duchenne Awareness Day: Anger as Blyth parents told of child's illness over the phone; A Northumberland dad has called on the Government to do more to help families of children suffering with Duchenne muscular dystrophy. |
|
|
Sep 7, 2015 |
543 |
Mum's Facebook appeal sees boy with rare muscle wasting condition receive 8,000 birthday cards; William Magee, who turns six on Wednesday, suffers from Duchenne Muscular Dystrophy, a genetic, terminal, muscle wasting condition. |
|
|
Aug 14, 2015 |
447 |
Carrier screening for Duchenne muscular dystrophy. |
|
|
Aug 1, 2015 |
1937 |
NHS delays Newcastle drug used to tackle a rare muscle-wasting condition; NHS England has halted the assessment of new Newcastle treatment Translarna used for boys with Duchenne muscular dystrophy. |
|
|
Jul 3, 2015 |
602 |
Phrixus Pharmaceuticals Receives Services From National Institutes of Health, NHLBI SMARTT Program to Produce Carmeseal-MD(TM) for Clinical Trial to Treat Duchenne Muscular Dystrophy. |
|
|
Jun 18, 2015 |
290 |
Blyth boy George Pegg delivers letter to Prime Minister in Muscular Dystrophy drug appeal; The 11-year-old Duchenne muscular dystrophy sufferer urged David Cameron to make the drug Translarna widely available. |
|
|
Jun 10, 2015 |
821 |
Duchenne muscular dystrophy diagnostics: it only gets better but some of the same challenges remain. |
Prior, Thomas W. |
Editorial |
Jun 1, 2015 |
1509 |
Noninvasive prenatal diagnosis of Duchenne muscular dystrophy: comprehensive genetic diagnosis in carrier, proband, and fetus. |
Yoo, Seong-Keun; Lim, Byung Chan; Byeun, Jiyoung; Hwang, Hee; Kim, Ki Joong; Hwang, Yong Seung; Lee, |
Report |
Jun 1, 2015 |
4893 |
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies. |
Liang, Yingyin; Chen, Songlin; Zhu, Jianzong; Zhou, Xiangxue; Yang, Chen; Yao, Lu; Zhang, Cheng |
Report |
May 1, 2015 |
5456 |
EpiCast Report: Duchenne Muscular Dystrophy - Epidemiology Forecast to 2023 - New Report Available. |
|
|
Apr 29, 2015 |
638 |
"Duchenne Muscular Dystrophy - Pipeline Review, H1 2015" now available at Fast Market Research. |
|
|
Mar 27, 2015 |
559 |
Bikers' [pounds sterling]10k pledge to help Sunderland youngster with Duchenne muscular dystrophy; Family of nine-year-old Matthew Brettell hoping to raise total of [pounds sterling]75,000 to adapt family home in Sunderland. |
|
|
Feb 3, 2015 |
612 |
Stem cells are defective in Duchenne muscular dystrophy. |
|
|
Jan 19, 2015 |
337 |
PTC Therapeutics begins rolling submission of Translarna's NDA to the US FDA for treating nonsense mutation Duchenne muscular dystrophy. |
|
|
Dec 24, 2014 |
238 |
PTC Therapeutics begins rolling submission of Translarna's NDA to the US FDA for treating nonsense mutation Duchenne muscular dystrophy. |
|
|
Dec 24, 2014 |
234 |
North expert's appeal to NHS over Duchenne treatment drug; WHAT IS DUCHENNE MUSCULAR DYSTROPHY? |
|
|
Dec 3, 2014 |
1435 |
Healing heart damage caused by Duchenne muscular dystrophy. |
|
Clinical report |
Nov 24, 2014 |
296 |
Duchenne muscular dystrophy: high-resolution melting curve analysis as an affordable diagnostic mutation scanning tool in a South African cohort. |
Esterhuizen, A.I.; Wilmshurst, J.M.; Goliath, R.G.; Greenberg, L.J. |
|
Nov 1, 2014 |
4343 |
Prosensa begins drisapersen's NDA submission to the US FDA for Duchenne muscular dystrophy. |
|
|
Oct 13, 2014 |
223 |
Prosensa begins drisapersen's NDA submission to the US FDA for Duchenne muscular dystrophy. |
|
|
Oct 13, 2014 |
219 |
Capricor to pursue clinical program for treatment of Duchenne muscular dystrophy. |
|
|
Oct 6, 2014 |
160 |
Capricor to pursue clinical program for treatment of Duchenne muscular dystrophy. |
|
|
Oct 6, 2014 |
160 |
'Early diagnosis has helped us plan for Alex's future' REAL LIFE STORIES Alex George was just a few days old when he was diagnosed with Duchenne muscular dystrophy after a simple heel prick test as a newborn. Mum Jeanette tells RACHEL MAINWARING why the early diagnosis, although a shock, meant they could plan for his future. |
|
|
May 20, 2014 |
1186 |
Viagra can treat Duchenne muscular dystrophy. |
|
|
May 8, 2014 |
144 |
Ward seeking to find cure to Duchenne muscular dystrophy with two-year grant. |
|
|
Feb 1, 2014 |
271 |
Corticosteroid treatment impact on spinal deformity in Duchenne muscular dystrophy. |
Sanzarello, Ilaria; Merlini, Luciano; Traina, Francesco; Rosa, Michele Attilio; Faldini, Cesare |
Report |
Jan 1, 2014 |
6948 |
Genetic testing for Duchenne/Becker muscular dystrophy in Johannesburg, South Africa. |
Kerr, R.; Robinson, C.; Essop, F.B.; Krause, A. |
Report |
Dec 1, 2013 |
4459 |
PPMD, Sarepta to launch programme for genetic testing of Duchenne muscular dystrophy patients in Q4 2013. |
|
|
Oct 21, 2013 |
138 |
Prosensa Holding NV's fourth exon-skipping compound PRO053 in clinical study for Duchenne muscular dystrophy. |
|
Clinical report |
Sep 9, 2013 |
259 |
Prosensa Holding NV's fourth exon-skipping compound PRO053 in clinical study for Duchenne muscular dystrophy. |
|
Clinical report |
Sep 9, 2013 |
245 |
Prosensa Holding NV secures EUR6m EU FP7 research grant for PRO045 for Duchenne muscular dystrophy. |
|
|
Aug 2, 2013 |
234 |
Prosensa Holding NV secures EUR6m EU FP7 research grant for PRO045 for Duchenne muscular dystrophy. |
|
|
Aug 2, 2013 |
230 |
New Plush Toy Cures the Smelly Gym Bag, Proceeds Benefit Duchenne Muscular Dystrophy Charity. |
|
|
Mar 26, 2013 |
447 |
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy. |
|
|
Feb 18, 2013 |
228 |
Stem cell approach shows promise for Duchenne muscular dystrophy. |
|
|
Jan 21, 2013 |
563 |
Coenzyme Q10 for Duchenne muscular dystrophy. |
Gaby, Alan R. |
Brief article |
Jul 1, 2012 |
214 |
Dependence on care experienced by people living with Duchenne muscular dystrophy and spinal cord injury. |
Martinsen, Bente; Dreyer, Pia |
Report |
Apr 1, 2012 |
7138 |
FEASIBILITY OF SHORT TANDEM REPEATS (STR) ANALYSIS FOR CARRIER DETECTION AND PRENATAL DIAGNOSIS IN FAMILIES WITH DUCHENNE MUSCULAR DYSTROPHY (DMD). |
Shaheen, Sajida; Ahmad, Suhaib; Hashim, Rizwan; Sattar, Abdus; Khan, Farooq Ahmad |
Report |
Dec 31, 2011 |
2694 |
Santhera's Catena slows decline in respiratory function in Duchenne Muscular Dystrophy. |
|
Clinical report |
Oct 19, 2011 |
115 |
AVI BioPharma Inc initiates Phase 2 trial of eteplirsen in higher doses in Duchenne muscular dystrophy patients. |
|
|
Aug 16, 2011 |
162 |
Molecular therapy promises treatment of Duchenne muscular dystrophy. |
|
|
Jul 26, 2011 |
328 |
Great Ormond Street Hospital patients take part in Duchenne Muscular Dystrophy clinical trial. |
|
|
Jul 26, 2011 |
643 |
Great Ormond Street Hospital patients take part in Duchenne Muscular Dystrophy clinical trial. |
|
|
Jul 26, 2011 |
643 |
Santhera presents promising data from Catena's DELPHI-E study in Duchenne Muscular Dystrophy. |
|
|
May 9, 2011 |
298 |
A medical approach to the care of children with Duchenne muscular dystrophy. |
Wilmshurst, Jo |
|
Apr 1, 2011 |
1049 |
Researchers find that Duchenne muscular dystrophy is basically a stem cell disease. |
|
|
Dec 13, 2010 |
776 |
Prosensa receives GBP7.5m milestone payment under programme with GlaxoSmithKline for Duchenne Muscular Dystrophy. |
|
|
Oct 13, 2010 |
154 |
AMT's gene therapy gains FDA Orphan Drug status for Duchenne muscular dystrophy. |
|
|
Sep 24, 2010 |
224 |
Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis. |
M., Sakthivel Murugan S.; Chandramohan, Arthi; Lakshmi, Bremadesam Raman |
Report |
Sep 1, 2010 |
5344 |
Acceleron Pharma's ACE-031 gets FDA Fast Track designation for Duchenne Muscular Dystrophy. |
|
|
Aug 30, 2010 |
133 |
Acceleron gets FDA orphan designation for ACE-031 in Duchenne Muscular Dystrophy. |
|
|
Aug 19, 2010 |
171 |
Acceleron Pharma's ACE-031 gets FDA Fast Track designation for Duchenne Muscular Dystrophy. |
|
|
Aug 6, 2010 |
133 |
Gene responsible for Duchenne muscular dystrophy can be repaired. |
|
|
Apr 16, 2010 |
217 |
BioMarin commences Phase I study of BMN 195 in Duchenne muscular dystrophy. |
|
|
Jan 12, 2010 |
180 |
AMT awarded innovation credit of EUR4.0m for Duchenne Muscular Dystrophy treatment. |
|
|
Jan 6, 2010 |
233 |
AVI BioPharma reports Phase Ib/II data for AVI-4658 in Duchenne muscular dystrophy. |
|
|
Dec 23, 2009 |
825 |
Glaxo's $679 million accord signals foray into rare diseases. |
|
Brief article |
Oct 19, 2009 |
235 |
Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years--four states, 2007. |
Romitti, P.; Puzhankara, S.; Mathews, K.; Zamba, G.; Cunniff, C.; Andrews, J.; Matthews, D.; James, |
Clinical report |
Oct 16, 2009 |
2710 |
Omega moulding helps hope for Javier fight Duchenne Muscular Dystrophy. |
|
Brief article |
Oct 1, 2008 |
311 |
Quantitative assay of deletion or duplication genotype by capillary electrophoresis system: application in Prader-Willi syndrome and Duchenne muscular dystrophy. |
Hung, Chia-Cheng; Chen, Chih-Ping; Lin, Shuan-Pei; Chien, Shu-Chin; Lee, Chien-Nan; Cheng, Wen-Fang; |
|
Dec 1, 2006 |
5277 |
Denaturing HPLC coupled with multiplex PCR for rapid detection of large deletions in Duchenne muscular dystrophy carriers. |
Hung, Chia-Cheng; Su, Yi-Ning; Lin, Chia-Yun; Yang, Chih-Chao; Lee, Wang-Tso; Chien, Shu-Chin; Lin, |
|
Jul 1, 2005 |
2551 |
Toilet training. (Respond). |
|
Brief Article |
Feb 1, 2003 |
161 |
Evaluation of microchip electrophoresis as a molecular diagnostic method for Duchenne muscular dystrophy. |
Ferrance, Jerome; Snow, Karen; Landers, James P. |
|
Feb 1, 2002 |
2426 |
Meeting the challenges: pulmonary complications in Duchenne muscular dystrophy. (EP Guide To Every Body Part 8). |
Braverman, Jane |
|
Dec 1, 2001 |
2877 |
Clinical and experimental results on cardiac troponin expression in duchenne muscular dystrophy. |
Hammerer-Lercher, Angelika; Erlacher, Petra; Bittner, Reginald; Korinthenberg, Rudolf; Skladal, Dani |
|
Mar 1, 2001 |
5700 |
MEDICAL RESEARCH UPDATE. |
CHAMALIAN, DAVID |
|
Feb 1, 2001 |
761 |
New tools for muscular dystrophy research. |
Seppa, Nathan |
Brief Article |
Sep 6, 1997 |
534 |
And downs. |
|
Brief Article |
Oct 28, 1995 |
464 |
Steroid slackens pace of muscular dystrophy. |
Fackelmann, Kathy A. |
|
Apr 27, 1991 |
588 |
Foot feat: transplant treats dystrophy. |
|
|
Jun 16, 1990 |
210 |
Facts about muscular dystrophy. |
|
pamphlet |
May 1, 1990 |
2784 |